Switching from Gilenya to Lemtrada could trigger MS activity

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

Switching from Gilenya to Lemtrada could trigger MS activity

Postby MSUK » Tue Feb 07, 2017 3:35 am

Switching from Gilenya to Lemtrada could trigger MS activity

According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya-lemtrada-could-trigger-ms-activity-070217
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2875
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Campath (Lemtrada, Alemtuzumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service